Myriad Genetics, Inc. to Present at the Morgan Stanley Global Healthcare Conference

SALT LAKE CITY, Aug. 30, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present at the Morgan Stanley Global Healthcare Conference, at 1:00 p.m. Eastern Time on Wednesday, September 12, 2012. The conference is being held at The Grand Hyatt New York in New York, New York.

Back to news